Respiratory Support in Spinal Muscular Atrophy Type I: A Survey of Physician Practices and Attitudes

نویسنده

  • M. Kathleen Moynihan
چکیده

Objective. To determine whether there is variability in the attitudes and practices of physicians regarding treatment of respiratory failure in children with spinal muscular atrophy type I (SMA type I) and, if so, whether this variation is associated with professional training. Methods. This was a descriptive, cross-sectional survey mailed to a randomly selected subset of the Child Neurology Society, pediatric members of the Society of Critical Care Medicine and to the membership of the Pediatric Interest Section of the American Academy of Physical Medicine and Rehabilitation. A scenario of a child with SMA type I in respiratory distress was followed by questions that explored practices and attitudes regarding mechanical ventilation. Results. Fifty-seven percent of intensivists (75 of 132), 39% physiatrists (61 of 155), and 34% of neurologists (61 of 155) responded. Specialists differed as to whether they offered and/or recommended respiratory support to patients with SMA type I. Intensivists were less likely to offer and recommend tracheostomy than physiatrists. Intensivists were also significantly less likely than physiatrists to agree with statements supporting the ethical necessity of noninvasive mechanical ventilation (NIMV) and intubation in the setting of an acute respiratory illness, and NIMV and tracheostomy in the setting of chronic respiratory failure. Although parallel differences were found between physiatrists and neurologists regarding their attitudes toward mechanical ventilation, no significant differences were detected between intensivists and neurologists. Finally, physicians who reported that a high percentage of their patients with SMA type I received “comfort care only” also tended to view mechanical ventilation, ie, use of NIMV for chronic respiratory failure, use of intubation for an acute respiratory infection, and use of tracheostomy for chronic respiratory failure as an unreasonable intervention in most circumstances. Conclusions. We found a wide variation in physician practice regarding the mechanical ventilation of patients with SMA type I. This study suggests a wide variation not only in what is recommended but also in what is actually offered to families of these children. Furthermore, the study suggests that physician training and attitudes affect recommendations regarding mechanical ventilation and ultimately family decision making. Pediatrics 2002;110(2). URL: http://www.pediatrics.org/ cgi/content/full/110/2/e24; spinal muscular atrophy, Werdnig-Hoffman disease, mechanical ventilation, physician attitudes, ethics, family decision making, survey. ABBREVIATIONS. SMA, spinal muscular atrophy; NIMV, noninvasive mechanical ventilation. Spinal muscular atrophy (SMA) type I, or Werdnig-Hoffman disease, is a devastating neuromuscular disease of childhood. Children with this disease typically have normal intelligence and remain alert and attentive to their environment, despite muscular weakness, and usually die from respiratory failure by age 2 years.1,2 Despite evidence from a small number of centers reporting success in prolonging life with mechanical ventilation,3–6 respiratory support for children with SMA type I is not widely accepted. Several important textbooks of pediatrics and pediatric neurology, for example, recommend against any mode of artificial ventilation for these patients.7,8 It is not clear whether these recommendations are based on the view that mechanical ventilation for these patients is not effective at sustaining life or that the quality of the life sustained is not of sufficient value. The purpose of this study was to describe the clinical practices of physicians regarding mechanical ventilation of patients with SMA type I. We also sought to explore the rationale underlying physician practices with the goal to understand better the basis for decision making. Our hypothesis was that wide variability exists in the care options presented and recommended to the families of children with SMA type I and that this variability may correlate with physician specialty, training, and attitudes.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes.

OBJECTIVE To determine whether there is variability in the attitudes and practices of physicians regarding treatment of respiratory failure in children with spinal muscular atrophy type I (SMA type I) and, if so, whether this variation is associated with professional training. METHODS This was a descriptive, cross-sectional survey mailed to a randomly selected subset of the Child Neurology So...

متن کامل

Spinal Muscular Atrophy Type I: Is It Ethical to Standardize Supportive Care Intervention in Clinical Trials?

The natural history of spinal muscular atrophy type I (SMA-I) has changed as improved medical support has become available. With investigational drugs for spinal muscular atrophy now in clinical trials, efficient trial design focuses on enrolling recently diagnosed infants, providing best available supportive care, and minimizing subject variation. The quandary has arisen whether it is ethicall...

متن کامل

Spinal Muscular Atrophy: A Short Review Article

Spinal muscular atrophy (SMA) is a genetic disorder which affect nervous system and is characterized with progressive distal motor neuron weakness. The survival motor neuron (SMN) protein level reduces in patients with SMA. Two different genes code survival motor neuron protein in human genome. Skeletal and intercostal muscles denervation lead to weakness, hypotony, hyporeflexia, respiratory fa...

متن کامل

SMN1 and NAIP genes deletions in different types of spinal muscular atrophy in Khuzestan province, Iran

 Background: Spinal muscular atrophy (SMA) is the second most common lethal autosomal recessive disease. It is a neuromuscular disorder caused by degenerative of lower motor neurons and occasionally bulbar neurons leading to progressive limb paralysis and muscular atrophy. The SMN1 gene is recognized as a SMA causing gene while NAIP has been characterized as a modifying factor for the clinical ...

متن کامل

O-27: Preimplantation Genetic Diagnosis in Prevention of Genetic Diseases -Diagnostic of Spinal Muscular Atrophy (SMA)

Background: Preimplantation genetic diagnosis - PGD is currently an established procedure allowing genetic research of oocyte or embryo before implantation to the uterus. Spinal muscular atrophy (SMA) is a neurodegenerative disorder, being the second most common lethal autosomal recessive disease in Caucasians, after cystic fibrosis. There are three clinically different types of which type I (W...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002